Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Venous thromboembolism refers to a medical condition characterized by the formation of blood clots in veins, typically occurring in the deep veins of the legs or pelvis. These clots can partially or completely obstruct blood flow, leading to various complications depending on their size and location. One of the most severe consequences is when a clot breaks free from its original site, travels through the bloodstream, and lodges itself in another organ—most commonly within one of the lungs' branches—resulting in a potentially life-threatening condition called pulmonary embolism. Venous thromboembolism can manifest differently among individuals; some may experience no symptoms at all, while others might notice swelling, pain, warmth, or redness around the affected area. Risk factors include prolonged immobility (such as during long periods of travel), surgery (especially orthopedic procedures), certain underlying conditions like cancer or heart disease, hormonal contraceptives use for an extended period of time, obesity, and genetic predisposition. Early diagnosis and appropriate management are crucial to avoid severe complications associated with venous thromboembolism and may involve anticoagulant medications and lifestyle modifications aimed at preventing further clot development.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Review looks at potential treatment targets in the tumor microenvironment.
3.
Even when they are not paying attention, children are still learning.
4.
The Benefits of Exercise for Substance Use Disorders.
5.
The top three drugs for multiple myeloma treatment upfront are four.
1.
The New Era of Oncology: Key Updates and Clinical Insights
2.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
3.
Decoding Granular Cell Tumor: What You Need to Know
4.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
5.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Navigating the Complexities of Ph Negative ALL - Part XI
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge